EMEA-002024-PIP02-22 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: P/0059/2023
Route(s) of administration: Oral use
Pharmaceutical form(s):
Capsule (hard)
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Tigecycline Accord
tigecycline
Soft Tissue Infections
Intraabdominal Infections
Bacterial Infections
Skin Diseases, Infectious
Date of authorisation:
Revision: 5
Last updated:
MedicineHumanAuthorised
Tygacil
tigecycline
Bacterial Infections
Skin Diseases, Bacterial
Soft Tissue Infections
Date of authorisation:
Revision: 34
Last updated:
MedicineHumanAuthorised
Tigecycline Accord
tigecycline
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
EMEA-000120-PIP01-07-M05 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0292/2014
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for solution for infusion
Decision date:
Last updated:
Compliance check: ✔
PIPHuman